Luis Solis Cayo

Luis Solis Cayo

Auto-generated profile, based on publicly available information

Luis Solis Cayo

Laboratorio de Genómica Microbiana, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
PRPedro E. Romero
Pedro E. Romero
Alejandra Dávila-BarclayAlejandra Dávila-Barclay
Alejandra Dávila-Barclay
GSGuillermo Salvatierra
Guillermo Salvatierra
LGLuis González
Luis González
DCDiego Cuicapuza
Diego Cuicapuza
PTPablo Tsukayama
Pablo Tsukayama
The evolution of SARS-CoV-2 variants with potentially increased transmissibility, virulence, and resistance to antibody neutralization poses new challenges for the control of COVID-19 (1), particularly in low- and middle-income countries (LMICs) where transmission remains high and vaccination progress is still incipient.

3 July 2021 in medRxiv
Verified
Preprint
Open access
PDF file
PRPedro E. Romero
Pedro E. Romero
Alejandra Dávila-BarclayAlejandra Dávila-Barclay
Alejandra Dávila-Barclay
GSGuillermo Salvatierra
Guillermo Salvatierra
LGLuis González
Luis González
DADiego Bernhard Cuicapuza Arteaga
Diego Bernhard Cuicapuza Arteaga
PTPablo Tsukayama
Pablo Tsukayama
We report the emergence of a novel lineage of SARS-CoV-2 in South America, termed C.37. It presents seven nonsynonymous mutations in the Spike gene (Δ247-253, G75V, T76I, L452Q, F490S, T859N) and a deletion in the ORF1a gene (Δ3675-3677) also found in variants of concern (VOCs) Alpha, Beta, and Gamma. Initially reported in Lima, Peru, in late December 2020, it now accounts for 97% of Peruvian public genomes in April 2021. It is expanding in Chile and Argentina, and there is evidence of onward transmission in Colombia, Ecuador, Mexico, the USA, Germany, and Israel. On June 15, 2021, the World Health Organization designated C.37 as Variant of Interest (VOI) Lambda.

28 November 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ADAlexander A. Dichter
Alexander A. Dichter
FWFlorian Winklmeier
Florian Winklmeier
DMDiana Munteh
Diana Munteh
WBWibke Ballhorn
Wibke Ballhorn
SBSabrina A. Becker
Sabrina A. Becker
VKVolkhard A.J. Kempf
Volkhard A.J. Kempf
Carrion’s disease is endemic to the South American Andes and is characterized by fatal hemolytic anemia. This neglected tropical disease is caused by Bartonella bacilliformis , a fastidious and slow-growing pathogen difficult in genetic manipulation. In this study, we determine that porin A and α/β-hydrolase are both necessary and sufficient for hemolysis induced by B. bacilliformis . These genes are identified through a screen of a Tn5 transposon mutant library. Using markerless deletion mutagenesis, porin A and α/β-hydrolase deletion mutants are generated and functionally analyzed by hemolysis assays. In silico analyses predict conserved biological functions and three-dimensional structures of the identified proteins, with the α/β-hydrolase showing structural similarity to known lipases. Site-directed mutagenesis of the α/β-hydrolase active site demonstrates that the catalytic triad (Ser205, Asp267, His310) is essential for its hemolytic function. Screening of a phospholipase inhibitor library comprising 27 bioactive compounds identifies compound 48/80 as a potent inhibitor of hemolysis, with activity in the micromolar range. Unraveling the molecular mechanisms underlying Carrion’s disease may facilitate the future development of anti-virulence therapies, a promising strategy particularly in the context of increasing antibiotic resistance of B. bacilliformis .

17 February 2025 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
GLGina Nilda Salvador Lujan
Gina Nilda Salvador Lujan
LCLiz Erika Cruz-Pio
Liz Erika Cruz-Pio
HCHedersson Calla
Hedersson Calla
DADamaris Rivera Ascencios
Damaris Rivera Ascencios
LCLuis Solís Cayo
Luis Solís Cayo
RGRuth García de la Guarda
Ruth García de la Guarda
Pseudomonas aeruginosa is an opportunistic pathogen associated with health care infections, it has high levels of antimicrobial resistance and is associated with hospital outbreaks. Early outbreak detection is a usual problem in hospitals, therefore, this study aimed to assess the clonal relationship of carbapenemaseproducing P. aeruginosa in a tertiary hospital in Lima, Peru. Twenty-four metallo β-lactamase-producing P. aeruginosa strains isolated from hospitalized patients were collected. The clonal relation was determined using the REP-PCR technique. REP-PCR band profiles were normalized, analyzed and combined using BioNumerics version 7.6 software. Molecular identification showed 19 different profiles and four clonal groups. We determined polyclonality among isolates. We did not find clonal dissemination among themetallo-β-lactamase-producing P. aeruginosa strains circulating in the hospital.